Sign inJoin waitlistJoin the waitlist

KT

Kathy Theall

Hematology & Oncology

Credentials: · ·

Research

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous…
The Lancet Oncology · 2016 · 1,453 citations
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
The Lancet Oncology · 2021 · 215 citations
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Journal of Clinical Oncology · 2022 · 204 citations

Angela DeMichele
8 papers
Hope Rugo
8 papers
Massimo Cristofanilli
5 papers
Eric Winer
4 papers
Erica Mayer
4 papers
Kathy Miller
4 papers
Richard Finn
4 papers
AW
Antonio Wolff
3 papers
BS
Bethany Sleckman
3 papers
Dennis Slamon
3 papers
Harold Burstein
3 papers
TT
Tiffany Traina
3 papers